Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Groups

Publications

  • Roman-Canal, B; Moiola, CP; Gatius, S; Bonnin, S; Ruiz-Miro, M; Gonzalez, E; Gonzalez-Tallada, X; Llordella, I; Hernandez, I; Porcel, JM; Gil-Moreno, A; Falcon-Perez, JM; Ponomarenko, J; Matias-Guiu, X; Colas, E

    EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer

    Cancers 11 -. .

    [doi:10.3390/cancers11060839]

  • Reijnen, C; van Weelden, WJ; Arts MSJP; Peters, JP; Rijken, PF; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Reques, A; Mancebo, G; Krakstad, C; Trovik, J; Haldorsen, IS; Huvila, J; Koskas, M; Weinberger, V; Minar, L; Jandakova, E; Snijders MPLM; van den Berg-van Erp, S; Küsters-Vandevelde HVN; Matias-Guiu, X; Amant, F; ENITEC-consortium; Massuger LFAG; Bussink J; Pijnenborg JMA

    Poor outcome in hypoxic endometrial carcinoma is related to vascular density

    BRITISH JOURNAL OF CANCER 120 1037-1044. .

    [doi:10.1038/s41416-019-0461-2]

  • Trapero, Carla; Vidal, August; Rodriguez-Martinez, Aitor; Sevigny, Jean; Ponce, Jordi; Coroleu, Buenaventura; Matias-Guiu, Xavier; Martin-Satue, Mireia

    The ectonucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in human endometrium: a novel marker of basal stroma and mesenchymal stem cells.

    Purinergic Signalling 15 225-236. .

    [doi:10.1007/s11302-019-09656-3]

  • Pereira-Veiga, T; Abreu, M; Robledo, D; Matias-Guiu, X; Santacana, M; Sanchez, L; Cueva, J; Palacios, P; Abdulkader, I; Lopez-Lopez, R; Muinelo-Romay, L; Costa, C

    CTCs-derived xenograft development in a triple negative breast cancer case

    INTERNATIONAL JOURNAL OF CANCER 144 2254-2265. .

    [doi:10.1002/ijc.32001]

  • Cuevas, D; Valls, J; Gatius, S; Roman-Canal, B; Estaran, E; Dorca, E; Santacana, M; Vaquero, M; Eritja, N; Velasco, A; Matias-Guiu, X

    Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma

    VIRCHOWS ARCHIV 474 585-598. .

    [doi:10.1007/s00428-018-02516-2]

  • Felip, I; Moiola, CP; Megino-Luque, C; Lopez-Gil, C; Cabrera, S; Sole-Sanchez, S; Muñoz-Guardiola P; Megias-Roda, E; Perez-Montoyo, H; Alfon, J; Yeste-Velasco, M; Santacana, M; Dolcet, X; Reques, A; Oaknin, A; Rodriguez-Freixinos, V; Lizcano, JM; Domènech C; Gil-Moreno, A; Matias-Guiu, X; Colas, E; Eritja, N

    Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

    GYNECOLOGIC ONCOLOGY 153 425-435. .

    [doi:10.1016/j.ygyno.2019.03.002]

  • Karpathiou, G; Matias-Guiu, X; Mobarki, M; Vermesch, C; Stachowicz, ML; Chauleur, Celine; Peoc'h, M

    Ovarian neuroendocrine carcinoma of metastatic origin: clues for diagnosis

    HUMAN PATHOLOGY 85 309-312. .

    [doi:10.1016/j.humpath.2018.08.015]

  • Mariscal, J; Fernandez-Puente, P; Calamia, V; Abalo, A; Santacana, M; Matias-Guiu, X; Lopez-Lopez, R; Gil-Moreno, A; Alonso-Alconada, L; Abal, M

    Proteomic Characterization of Epithelial-Like Extracellular Vesicles in Advanced Endometrial Cancer

    JOURNAL OF PROTEOME RESEARCH 18 1043-1053. .

    [doi:10.1021/acs.jproteome.8b00750]

  • MATIAS-GUIU GUIA, XAVIER; Condom, Enric

    Similarities and Differences in Neuroendocrine Tumors of the Male and Female Genital Tracts and Urinary Tract

    Gynecologic and Urologic Pathology: Similarities, Differences and Challenges 233-244. .

    [doi:10.1017/9781316756423.022]

  • Georgouli, M; Herraiz, C; Crosas-Molist, E; Fanshawe, B; Maiques, O; Perdrix, A; Pandya, P; Rodriguez-Hernandez, I; Ilieva, KM; Cantelli, G; Karagiannis, P; Mele, S; Lam, H; Josephs, DH; Matias-Guiu, X; Marti, RM; Nestle, FO; Orgaz, JL; Malanchi, I; Fruhwirth, GO; Karagiannis, SN; Sanz-Moreno, V

    Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment

    Cell 176 757-77423. .

    [doi:10.1016/j.cell.2018.12.038]

  • del Rosario Taco Sanchez, Maria; Soler-Monso, T; Petit, A; Azcarate, J; Lasheras, A; Artal, C; Gil, M; Falo, C; Pla, MJ; Matias-Guiu, X

    Digital quantification of KI-67 in breast cancer

    VIRCHOWS ARCHIV 474 169-176. .

    [doi:10.1007/s00428-018-2481-3]

  • Stewart CJR; Crum, CP; McCluggage, WG; Park, KJ; Rutgers, JK; Oliva, E; Malpica, A; Parkash, V; Matias-Guiu, X; Ronnett, BM

    Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 38 75-92. .

    [doi:10.1097/PGP.0000000000000553]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment